CERC ASIA PTE. LTD.
Last Updated: 13 Apr 2026
CERC-Asia is the Asian subsidiary of CERC, a renowned European CRO specializing in interventional cardiovascular medicine. Since 2008, CERC-Europe has demonstrated expertise in regulatory guidance, trial design, strategic planning, and global study management. With a proven track record in supporting clinical trials in Asia, CERC-Asia aims to provide comprehensive support for cardiovascular clinical research in the region, including local project management, logistics, and regulatory compliance. Our mission is to underpin the development of cutting-edge cardiovascular research in Asia, driven by CERC's commitment to excellence and patient safety.
Country of registration | Singapore |
Registration number | 201619744G |
Local SIC | |
Incorporation date | 19 Jul 2016 |
Company age | 9 years 10 months |
Official entity type | Private Limited Company |
No. of officers | 8 |
Contact
Address:
101 CECIL STREET, #10-01, TONG ENG BUILDING, Singapore 069533
Phone number:
Access Key Decision Makers
This is the legal entity page of CERC ASIA PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (2)
- View MoreCERC-Asia is the Asian subsidiary of CERC, a renowned European CRO specializing in interventional cardiovascular medicine. Since 2008, CERC-Europe has demonstrated expertise in regulatory guidance, trial design, strategic planning, and global study management. With a proven track record in supporting clinical trials in Asia, CERC-Asia aims to provide comprehensive support for cardiovascular clinical research in the region, including local project management, logistics, and regulatory compliance. Our mission is to underpin the development of cutting-edge cardiovascular research in Asia, driven by CERC's commitment to excellence and patient safety.
- View MoreCERC is a specialized CRO driven by physicians recognized for their expertise in cardiovascular research. Their renown and expertise in this field have enabled them to generate optimal interaction with their industrial partners and other medical research teams focusing on the development of innovative techniques, concepts and treatments. The CERC was created with the aim of establishing a reputable high-quality dedicated CRO in Europe. Its objectives are to underpin European clinical trials and academic leadership, act as a global CRO and support young scientific leaders.
This is the legal entity page of CERC ASIA PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Revenue | < 1m |
Share Capital - Ordinary shares | SGD 50,000 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of CERC ASIA PTE. LTD.?
- Where is CERC ASIA PTE. LTD.'s headquarter?
- What is CERC ASIA PTE. LTD.'s contact number?
- What CERC ASIA PTE. LTD.'s spending power?
- Does CERC ASIA PTE. LTD. have a presence in the domain it operates in?